Stevenage Bioscience Catalyst Competitors

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio

MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal and Metabolic Diseases, and Infection and Vaccines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centres, with additional sites in Cambridge, UK and South San Francisco, CA. For more information, please visit www.medimmune.com

Genomics England works with the NHS to bring forward the use of genomic healthcare and research in Britain to help people live longer, healthier lives. Genomics is a ground-breaking area of medicine that uses our unique genetic code to help diagnose, treat and prevent illnesses. Thanks to advanced technology, scientists can now compare many people’s genetic code to make new discoveries that continually improve genomic healthcare. In 2013, Genomics England and the NHS launched the 100,000 Genomes Project, demonstrating how genomics insights can help doctors across the NHS, and building a foundation for the future by assembling a unique dataset. Genomics England is now supporting the NHS to deliver genomic testing for patients as part of routine healthcare, and providing the health data and technology that researchers need to make new discoveries and create more effective, targeted medicines. We work with thousands of people – patients, doctors and scientists – to increase our collective knowledge and enable faster and deeper genomic research, to bring genomic healthcare to all who need it.